Загрузка...
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Tuberculosis is the leading infectious disease killer globally due to a single pathogen. Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine (bacille Calmette Guerin, BCG), the global tuberculosis epidemic is inadequately controlled. Novel, effective vaccine(s) are a...
Сохранить в:
| Опубликовано в: : | Semin Immunol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Academic Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7786643/ https://ncbi.nlm.nih.gov/pubmed/33279383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2020.101431 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|